Light on the brain: new study tests if a head device can sharpen memory
NCT ID NCT07287527
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study tests whether transcranial photobiomodulation (t-PBM), a light-based brain therapy, can improve memory and thinking in older adults with amnestic mild cognitive impairment (aMCI). Sixty participants will receive either active or sham t-PBM during eight sessions of cognitive training. Researchers will measure changes in memory tests and brain scans to see if the light treatment helps brain areas communicate better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMCI - AMNESTIC MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NPIstanbul Brain Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uskudar University, Faculty of Medicine
RECRUITINGIstnabul, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial photobiomodulation (t-PBM) device delivering near-infrared light
What this could lead to
If it works, this could point toward a non-invasive, drug-free way to boost memory and slow cognitive decline in people at risk for Alzheimer's disease.
What could go wrong
This is a small, early-stage study with only 60 participants. The treatment may not improve memory more than a placebo, and results may not apply to everyone with mild cognitive impairment.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.